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Metabolic disturbance as a cause of recurrent hematuria in children.
To evaluate metabolic disturbance as a cause of hematuria, 250 chil-
dren, aged eight months to fourteen years, with recurrent hematuria
were studied. In the present series, metabolic disturbance was mainly
due to idiopathic hypercalciuria (IH), the most common etiology of
hematuria without proteinuria in childhood. Sixty-seven (27%) of the
children had IH, ten children (4%) had hyperuricosuria, and 27 (11%)
had nephrolithiasis. To better characterize the IH into renal (RH) or
absorptive hypercalciuria (AH) subtypes, 45 of the 67 children (ranging
age from six to twelve years) were further submitted to an oral calcium
load test. Eighteen patients (40%) had AH, 7(15.5%) RH and 20(44.4%)
could not be classified as having AH or RH [indeterminant (ID)
idiopathic hypercalciuria group]. Intravenous pyelography or ultra-
sound were normal in all children. The oral calcium load test may be
useful in characterizing the subtype of IH in some children; however, a
great number of the IH children were characterized as indeterminant.
Also hyperuricosuria, recently described as another metabolic distur-
bance associated with hematuria, may be an important cause of
recurrent hematuria in children.
Idiopathic hypercalciuria (IH), a disorder characterized by an
increase of calcium urinary excretion higher than 4 mg/kg/day,
is a frequent metabolic disorder in childhood and has been
associated with clinical findings such as urolithiasis [I], hema-
tuna [2], and juvenile rheumatoid arthritis [3]. Recently, an
association between asymptomatic hematuria and hypercalci-
uria prior to clinical or roentgenographic evidence of urolithia-
sis has been emphasized [2, 4, 5]. In 1981, Moore [51 reported
that hematuria without urolithiasis was the initial clinical man-
ifestation in eight of twenty-three children with IH. Recently,
hyperuricosuria has also been associated with hematuria [6].
However, evaluation of urinary calcium and uric acid excre-
tion has not been routinely carried out in children with macro-
scopic or intermittent hematuria, and the prevalence of IH as
well as hyperuricosuria (HU) in a population of children with
hematuria remains unknown in most pediatric centers. In view
of the reported familial incidence of IH [3, 7, 8], it was also
interesting to find that in 86% of children studied with gross
hematuria and a family history of urolithiasis, hypercalciuria
was present [2]. On the basis of the pathogenic mechanisms two
major subtypes of IH, renal and absorptive hypercalciuria, can
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be distinguished utilizing an oral calcium load test [9]. The
characterization of these groups of IH have been reported to be
of clinical value in formulating a rational therapeutic regimen
for children with IH associated with hematuria and/or urolithi-
asis [10]. This paper therefore, was undertaken to analyze
metabolic disturbances associated with hematuria and to assess
the clinical value of the oral calcium load test in characterizing
IH subtypes in children. Furthermore, we examined the clinical
evolution of children with IH, who were submitted to different
therapeutic approaches based upon classification by the oral
calcium test.
Methods
During the last five years (1984 to 1989), 250 children with
recurrent hematuria (more than 5 red blood cells per high
powered field), aged 8 months to 14 years old were evaluated in
our nephrology department. Twenty-seven percent of those
children had only hypercalciuria as a cause of the hematuria
without proteinuria. The presenting symptom was microscopic
in 18% and gross hematuria in 82%. Among them, we studied
the first 45 of a total of 67 children with IH with oral calcium
load test. Ten healthy children, aged 5 to 9 years, without
history of renal disease were used as controls. After an Ethical
Committee approval and a consent obtained from parents of the
patients and control group, each child was submitted to an oral
calcium load test similar to that described for Pak Ct al which
was adapted to children by Stapleton Ct al [9, 11]. On their
habitual diets, the patients fasted from 8 p.m. of the preceding
evening to 8 a.m. the next morning, except for 200 ml of
distilled water at 8p.m., 10p.m. and 6a.m. Urine was collected
for two hours and, after a light breakfast, an oral calcium load
(1 g/l.73 m2 of body surface area) was administered. An
equilibration period of 30 minutes was followed and a new
collection of urine was obtained over the next 210 minutes.
Blood samples were collected just before calcium administra-
tion. Serum calcium, uric acid and phosphorus were measured,
a creatinine clearance was calculated and urinary cyclic AMP
(cAMP) determined. Three 24-hour urinary collections, with a 7
to 10 day interval, were analyzed for uric acid, creatinine and
calcium excretion in each child. Three 24-hour samples of urine
were collected as there was a variability in the daily UCa
excretion, and the highest value was chosen for the IH diagno-
sis because of its relationship with a high risk of nucleation.
Cyclic AMP was measured by the method of Broadus [12],
calcium by atomic absorption technique (290-B Perkin Elmer,
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Atomic Spectrophotometer model; Perkin-Elmer, Norwalk,
Connecticut, USA); uric acid by Follin and Denis' technique
[13]; phosphorus by Fishe and Subbarrow method [141 and
creatinine by Jaffé technique [15]. All patients were submitted
to intravenous pyelogram and/or ultrasound examinations. Pa-
tients with RH were submitted to a prospective treatment with
hydrochlorothiazide (0.5 mg/kg/day), and those with AH were
treated with rice bran or calcium restricted diet (400 to 500 mg
of calcium/day) for three to twelve months. Children with HU
were treated with allopurinol and/or purine restricted diet for 1
to 3 months. For indeterminant IH potassium citrate was
administered (0.5 mEq/kg'day). Urinary excretion of calcium,
uric acid, urinalysis and urine culture were performed monthly.
The patients have been followed in our outpatient clinic.
Laboratory criteria
The diagnosis of HI was established by an urinary calcium
excretion > 4 mg/kg/day in one or more of the three 24-hour
urinary collections, with normal serum calcium concentration
while ingesting an habitual diet [16]. The data provided by
Stapleton et al [3] is similar to that observed in previous
research with 140 Brazilian children: mean urinary calcium
excretion was 1.6 0,1 mg/kg/day (X SE) in children aged 2
to 7 years; 1.9 0.1 mg/kg/day in children aged 7 to 12 years
and 1.2 0.2mg/kg/day in children aged 12 to 18 years. Hence
4 mg/kg/day (X 2 SD) was considered to be the upper limit for
24-hour urinary calcium excretion. Renal hypercalciuria (RH)
was defined as a fasting Uca/Ur concentration ratio greater
than 0.21 [9]. Absorptive hypercalciuria (AH) was defined as a
fasting UCa/UCr concentration rate less than 0.21 and a urinary
Ca/Cr index greater than 0.27 after calcium administration [10].
Finally, a third group of children with IH was characterized by
24-hour urinary calcium excretion greater than 4 mg/kg/day, but
the oral calcium load test was not able to define if the children
had an AH or RH subtype. Those children had Ua/Ur fasting
ratio less than 0.21 and loading less than 0.27. Therefore they
were characterized as the indeterminant (ID) IH group.
Uric acid hyperexcretion is considered to be excessive if
greater than X 2 SD for age per 24 hours [171, similar to the
results in normal children in São Paulo [16]: 615 mg/day (X 2
SD) in children aged 2 to 7 years; 580 mg/day in children aged 7
to 12 years and 628 mg/day in children aged 12 to 18 years.
Statistical analysis were performed by Student's unpaired
t-test and the Fisher test for the L/F ratio (Table 2). Results are
expressed as mean standard error (X SE).
Results
Metabolic disturbances were the common etiologies of recur-
rent hematuria in childhood (Table 1), IH occurred in 27%, uric
acid hyperexcretion was present in 4%, and 11% had nephroli-
thiasis. In the IH group 11 of 45 (24.4%) children presented with
uric acid hyperexcretion. The first group of forty-five children
with hematuria and hypercalciuria were submitted to the oral
calcium load test. There were 20 female and 25 male subjects,
evenly distributed throughout all age groups, with an age range
of 6 to 12 years old (mean 8.8 0.4 years). The control group
of 10 children (6 boys and 4 girls) ranged in ages from 5 to 9
years (mean 8.4 0.9 years), which was similar to the age range
of IH children. Children with HU (6 female and 4 male) had a
mean age of 8.6 years.
Table 1. Recurrent hematuria in children: Etiology
Number Percent
Mean age
years
Hypercalciuria 67 27 8.7 0.5k'
Uric acid hyperexcretion 10 4 8.6 1.0
Nephrolithiasis 27 11 9.1 0.2
Glomerulopathies
Berger 15 6 10.5 0.8
Alport 19 7 7.7 0.6
Others 45 18 9.8 0.9
Urinary tract infection 14 6 7.5 1.1
Renal malformation 8 3 6.3 0.5
After renal trauma 2 I 11.0 0.7
Without diagnosis 43 17 9.3 1,7
Total 250 100
a X SE
The incidence of urolithiasis in the control group was null.
However, the IH group had positive family history in 16 of 45
children (35.5%); the RH group had positive family history in 4
of 7 children (57%), the AH group had positive family history in
9 of 18 (50%), the ID group had positive family history in 8 of 20
children (40%), and the HU group had positive family history in
5 of 10 children (50%).
No statistical differences were observed in serum concentra-
tions of calcium, uric acid or phosphorus serum concentrations
among the five groups. Also, no alterations in glomerular
filtration rate, as estimated by creatinine clearance, were found.
The higher 24-hour urinary calcium excretion in children in the
renal, absorptive and ID groups was significant, especially
when compared with the control group (P < 0.0005; Table 2).
The mean urinary calcium was 1.6 0.3 mg/kg/day in the
control group, .6.8 1.0 mg/kg/day in children with RH, 6.6
0.6 mg/kg/day in the AH group and 6.0 0.3 mg/kg/day in the
ID. Urinary cyclic AMP excretion was normal in all children
(Table 2).
According to their responses, children were classified as
having renal hypercalciuria, absorptive hypercalciuria or inde-
terminant IH (ID). Before calcium administration, no significant
differences in the urinary Ca/Cr concentration ratio were ob-
served among the control group (0.12 0.02, AH (0.07 0.01),
or ID groups (0.09 0.01), as shown in Table 2. However,
children with RH showed a significant difference with this ratio,
0.22 0.01 (P < 0.0005) when compared with the control
group.
After the calcium load, urinary Ca/Cr concentration ratios for
both RH (0.30 0.01) and AH (0.27 0.03) groups were
significantly greater than those observed in the control group
(0.15 0.02), P < 0.0005 and P < 0.0025, respectively. The
increase in 1Ja/U. concentration ratio on children with AH,
when compared with the fasting ratio, was almost four times
greater. This increment was not found in the control group or in
patients with RH or ID.
Urinary uric acid excretion was elevated in 10 children (Table
3). Calcium excretion was normal in each child. The intrave-
nous pyelogram and/or ultrasonography examinations were
normal in all evaluated children (100%).
After the treatment with hydrochlorothiazide, calcium re-
striction diet (or rice bran), potassium citrate, allopurinol or
purine restricted diet, urinary calcium or uric acid concentra-
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Table 2. Urinary values for calcium and cAMP
Ratio (Uca/Ucr) Urinary values
Fasting Load Ca cAMP
(F) (L) L/F_________ mg/kg/24 hr nmolldl GFR
Control (N = 10) 0.12 0.02 0.15 0.02 1.25 1.6 0.3 2.7 1.5
Children with
IH (N = 45) 0.12 0.01 0.26 003b 2.15 6.7 0.5' 1.9 0.6
RH (N = 7) 0.22 0•01b 0.30 0.01k' 1.36 6.8 1.0k' 2.5 0.3
AH (N = 18) 0.07 0.01 0.27 0.03k' 3.86l 6.6 0.6l 1.5 0.2
ID (N = 20) 0.09 0.01 0.15 0.01 1.66 6.0 0.3' 1.9 0.2
Abbreviations are: cAMP, Cyclic adenosine monophosphate; IH, idiopathic hypercalciuria; RH, renal hypercalciuria; AH, absorptive
hypercalciuria; ID, indeterminant; GFR, glomerular filtration rate; (L/F), increment of the ratio Ua/Ur from fasting to load of calcium intake.
a x SE
b p < 0.05 vs. control
Table 3. Uric acid hyperexcretion in childhood
UUrAc
Patient Sex years mg/kg mg/day mg/i .73 m2 BSA
1 F 8 . 2.7 1100 1655
2 M 9 2.0 650 938
3 M 8 2.2 690 1356
4 F 3 2.6 810 2335
5 F 9 1.0 800 1281
6 M 3 3.0 518 1318
7 F 12 0.9 936 1157
8 F 13 1.0 1100 1410
9 M 11 3.0 650 903
10 F 10 1.0 2700 5190
Abbreviations are: F, female; M, male; UUrAc, urinary uric acid.
tions returned to normal in each patient. The decreased urinary
calcium excretion was accompanied by disappearance of hema-
tuna in four patients with HU. None of the treated patients
developed renal stone formation, while the 5 of 17 patients not
treated developed stones and 4 of 12 irregular treated patients
developed nephrolithiasis (Table 4). Irregular treatment is char-
acterized as spontaneous interruption of treatment after one or
two months, followed by sporadic treatment at irregular inter-
vals.
Discussion
Increased urinary calcium excretion (IH) is an important
metabolic event since it accounts for 38 to 70% of calculi
disease [1, 18], 26 to 36% of childhood hematuria [19) and it is
observed in 3 to 7% of normal children [10, 161. There are many
reports suggesting IH as a main cause of recurrent hematuria in
children [191, but only a few reports describe hyperuricosuria as
a possible cause of recurrent hematuria in children [61 and
adults [20]. Bayle and Mancheno [61 recently reported five
cases of children with hematuria due to hyperuricosuria and
have verified the disappearance of the hematuria when uricos-
uria was reduced. Among the 250 children in the present study
who had hematuria, a striking 31% of the cases were due to
metabolic disturbances. IH may result from at least two patho-
genetical mechanisms, namely an excessive intestinal absorp-
tion of calcium (AH) or an inadequate tubular reabsorption of
calcium from the glomerular filtrate (RH) [9]. However, it is not
clearly established whether AH and RH are two pathological
entities or if they represent different manifestations of the same
Table 4. IH and hematuria: Evolution during 6 to 12 months
Treatment
Uca mg/kg/day Renal
stone
formationbefore after
RH
Treated (N = 3) HCT 6.8 2.7 0/3
Not treated — 7.2 5.2 1/1
(N = 1)
Irregular treatment HCT/— 5.7 4.2 2/3
(N =3)
AH
Treated (N = 8) diet or
rice bran
6.5 3.0 0/8
Not treated — 5.2 4.1 2/6
(N = 6)
Irregular treatment diet/— 7.1 3.7 2/4(N = 4) rice bran
ID
Treated (N = 5) potassium
citrate
6.4 5.1 0/5
Not treated — 5.2 3.9 2/10
(N = 10)
Irregular treatment potassium 6.1 4.0 0/5(N = 5) citrate/—
Abbreviations are: RH, renal hypercalciuria; AH, absorptive hyper-
calciuria; IH, indeterminant hypercalciuria; HCT, hydrochlorothiazide.
disease [21]. It is also possible that both subtypes are related to
a same complex of proximal renal tubular defect [1]. However,
distinguishing these two subtypes is thought to be of consider-
able clinical importance, since each of them may require a
different therapeutic approach [21—231. In AH, treatment is
directed toward decreasing intestinal calcium absorption with
neutral phosphate or rice bran supplements [22] and/or with a
low calcium diet [23]. On the other hand, a thiazide diuretic
and/or amiloride is effective in reducing calcium excretion in
RH during long-term therapy [211. In AH, urinary calcium
excretion is only transiently reduced after a period of thiazide
administration [18]. Thiazide therapy was prescribed for chil-
dren with RH until urinary calcium return to normal (3 to 12
months). The benefit of this treatment and the long-term risk of
hydrochlorothiazide administration are unclear [1, 21]. During
the last two years we have had the opportunity of treating and
following children with IH in order to verify if the treatment had
any clinical benefit. As previously described by Roy et al [4],
five children with recurrent hematuria were discovered to have
IH only after a passage of calcium oxalate stone. All five
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children had been evaluated months to years previously for
unexplained hematuria without evidence of urinary calculi at
the time of initial evaluation [4]. Similarly, in the present series
of 45 children with JR and hematuria, radiological studies with
either intravenous pyelogram or ultrasound (or both) were
normal in all children. No specific cause for the increase in
urinary calcium or uric acid excretion were determined, and
hence it was compatible with the diagnosis of IH and HU. Uric
acid levels in plasma being the same in normal children and
those children with hyperuricosuria suggest that an overproduc-
tion of urate could be responsible for this process. Long-term
observation showed a high incidence of urolithiasis in these
children with hematuria and IH. Within two years, 11 of 45
(24%) of the IH group and 2 of 10 (20%) of the RU group
developed renal stones after variable periods of recurrent
hematuria (unpublished data).
The present study suggests that routine measurement of
urinary calcium and uric acid excretion is warranted in children
with unexplained hematuria, and that an oral calcium load test
appears to distinguish RH from AH in some children found to
have hypercalciuria. In this series 7 of 45 (15%) and 18 of 45
(40%) presented RH and AH subtypes of IH, respectively.
Moreover, our data also suggest that lEt and HU are more likely
to be the cause of hematuria in children in whom there is a
family history of urolithiasis [7, 81. In such children, a contin-
ued surveillance for warning signs of calculi is very important,
as reported by Stapleton [191 in a prospective multicenter study
that described IH in 76 (35%) patients among 215 children with
hematuria, and 74% of the IH group had at least one relative
with urolithiasis [19].
In conclusion, these data indicate that metabolic disturbance
is the most common definable cause of hematuria in our
population of children. Therefore, it is very important to
consider hypercalciuria and uric acid hyperexcretion during the
investigation of hematuria. lEt and hyperuricosuria have their
origins in childhood; early diagnosis and appropriate treatment
may reduce the incidence of renal stones in children as well as
in adults.
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